UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039725
Receipt number R000045248
Scientific Title A national survey of ADPKD patients in CKD stage G5
Date of disclosure of the study information 2020/05/01
Last modified on 2024/03/09 09:23:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A national survey of ADPKD patients in CKD stage G5

Acronym

ADPKD G5 Registry

Scientific Title

A national survey of ADPKD patients in CKD stage G5

Scientific Title:Acronym

ADPKD G5 Registry

Region

Japan


Condition

Condition

autosomal dominant polycystic kidney disease(ADPKD)

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We make ADPKD G5 Registry, and clarify the actual situation of ADPKD patients in CKD stage 5.
We investigate the difference the decline of renal dysfunction in CKD stage G5, depending on whether or not the patient has been exposed to Tolvaptan in CKD stage G3-4.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the actual situation of ADPKD patients in CKD stage 5
the decline of renal dysfunction in CKD stage G5

Key secondary outcomes

the rate of increase in the TKV


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. age over 20 at May 2014
2. ADPKD patients in CKD stage G5 refferred to the institution which participates in this study, from May 2014 to September 2019
3. The patients who were obtained of the agreement

Key exclusion criteria

The patients who are not willing to enroll the study and who are judged inappropriate the study by responsibility doctors.

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Satoru
Middle name
Last name Muto

Organization

Juntendo University, Graduate School of Medicine

Division name

Department of Urology

Zip code

1138431

Address

3-1-3, Hongo, Bunkyo-ku, Tokyo

TEL

03-5802-1227

Email

s-muto@juntendo.ac.jp


Public contact

Name of contact person

1st name Akinari
Middle name
Last name Sekine

Organization

Toranomon Hospital

Division name

Nephrology Center

Zip code

1058470

Address

2-2-2, Toranomon, Minato-ku, Tokyo

TEL

03-3588-1111

Homepage URL


Email

akinari-s@toranomon.gr.jp


Sponsor or person

Institute

a Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan

Institute

Department

Personal name



Funding Source

Organization

a Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Juntendo University

Address

3-1-3, Hongo, Bunkyo-ku, Tokyo

Tel

03-3814-5672

Email

s-muto@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

188

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Due to delay in completing the paper.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events

None

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 10 Month 24 Day

Date of IRB

2019 Year 12 Month 27 Day

Anticipated trial start date

2019 Year 12 Month 27 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information

We extract the following observation contents.
(1) Basics information: Sex, age, family history, hepatic cyst, cerebral aneurysm, valvular disease of the heart, diverticula of colon, diabetes, height, weight, blood pressure, dialysis, presence or absence of depression treatment, presence of the anemia, Tolvaptan therapy
(2) Blood test: Hb, Ht, TP, Alb, UN, Cre, eGFR, cystatin C, UA, Na, K, AST, ALT, LDH, ALP, GTP, GA, HbA1c
(3) Urinary test: Hematuria, Proteinuria
(4) Total Kidney Volume(TKV), longer axis of the kidney


Management information

Registered date

2020 Year 03 Month 06 Day

Last modified on

2024 Year 03 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045248


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name